Overall Technical outlook

Price Summary

On 2026-07-01, NATCO Pharma Limited's stock began at 939.8, climbed to 951.5, dropped to 915.75, and had -1.45% to end at 926.2, with a volume of 576989 shares.
Over the past year, the stock's highest price was 1206.0, and its lowest was 792.95.

Technicals

Support and Resistance: The price is currently at 926.2, supported by 857.85 and resisted by 946.1. This indicates a range where 857.85 may provide a base for the price, while 946.1 serves as a cap on further upward movement for NATCOPHARM.
NATCOPHARM supportResistance 7a2a62
Support/Resistance for NATCOPHARM


Aroon: Aroon's bullish trend continues, with Aroon Up at the 100 level, indicating sustained market strength for NATCOPHARM. This trend warrants further exploration alongside other indicators to fully understand its implications and potential future direction.
NATCOPHARM aroon 7a2a62
Aroon chart for NATCO Pharma Limited


Bol. Bands: The current reading of the BOLL BANDS is neutral for NATCOPHARM, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
NATCOPHARM bbands 7a2a62
Bolinger Bands chart for NATCO Pharma Limited


Parabolic SAR: The PSAR for NATCOPHARM maintains a bullish outlook, establishing a crucial support level that may help maintain the current upward momentum. This strong support suggests that the market is poised to continue its upward trend, providing confidence in the ongoing bullish sentiment.
NATCOPHARM psar 7a2a62
Parabolic Stop and Reverse chart for NATCO Pharma Limited


Stochastic: The stochastic indicator is currently bullish, with the K-line exceeding both the D-line and the 80 level. This configuration indicates robust upward momentum, suggesting that the market may experience further gains. Investors may interpret this as a positive signal for continued upward movement.
NATCOPHARM stoch 7a2a62
Stochastic chart for NATCO Pharma Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
NATCOPHARM trippleSMA 7a2a62
Tripple SMA chart for NATCO Pharma Limited


A thorough analysis of a company involves looking at both its fundamentals and technical data. The fundamentals, including revenue, profitability, and management quality, offer insight into the company's long-term value. Additionally, understanding the broader industry context, such as market competition and regulatory challenges, helps to better interpret the company's stock performance. By combining both fundamental and technical analysis, you can derive more meaningful inferences about the company's future prospects.